NB
Neurocrine Biosciences Inc.
NBIX· Health Care· BiotechnologyS&P 400
Close · 10/09/2026
156.57
1D
+0.92%52-week range
122.14 – 186.12
Volume
8,95,200.00
Price history
NBIX
11/08/2026 to 10/09/2026
O 154.38 H 159.94 L 152.04
1W-0.77%
1M-3.32%
3M-2.67%
6M+20.87%
1Y+8.60%
3Y+42.43%
5Y+63.79%
MAX+58.17%
Fundamentals
as of 10/09/2026- Market cap
- $15.92B
- Shares out
- 101.65M
- P/E (trailing)
- 22.56
- P/E (forward)
- 13.00
- EPS (trailing)
- 6.94
- Beta
- 0.38
- Profit margin
- 20.91%
- P/B
- 4.31
- Return on equity
- 19.10%
SEC financial statements
59 quarterly and 17 annual periods through 30/06/2026.
Details
- Ticker
- NBIX
- Index
- SP400
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 10/09/2026.
Tracked by Congress
1 filer · 0 on watchlist · 1 buy · 1 sell · R: 2
- 17/06/2025Lisa McClainSell+Neurocrine Biosciences, Inc. - Common Stock$1,001–$15,000
- 11/06/2025Lisa McClainBuyNeurocrine Biosciences, Inc. - Common Stock$1,001–$15,000